arrow
L

Lesley S. Park

Stanford University
H指数:28
被引数:3,112

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of SARS-CoV-2 breakthrough infection on short-term CD4 count among adults with HIV in the United States from 2020-2022

2020-2022年美国HIV感染者中SARS-CoV-2突破性感染对短期CD4计数的影响

2026-05-070
OA
Availability of Cancer Screening Across HIV Treatment Sites in the IeDEA Consortium

艾滋病治疗点癌症筛查的可及性:IeDEA联盟研究

2026-04-160
OA
Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 (COVID-19) Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout
2023-03-029
OA
Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US
2022-10-1327
OAAI
Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States
2022-06-0752
OAAI
Statin exposure and risk of cancer in people with and without HIV infection

有和没有HIV感染的人的他汀类药物暴露和癌症风险

AIDS
IF3.1
2021-11-117
OA
Risks of Opportunistic Infections in People With Human Immunodeficiency Virus With Cancers Treated With Chemotherapy

接受化疗的人类免疫缺陷病毒癌症患者的机会性感染风险

2021-07-199
OAAI
Differences in Pathology, Staging, and Treatment between HIV+ and Uninfected Patients with Microscopically Confirmed Hepatocellular Carcinoma
2020-01-096
OAAI
Short-term outcomes for lung cancer resection surgery in HIV infection
AIDS
IF3.1
2019-07-0114
OAAI
Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study
2019-04-0150
OAAI
Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America

北美接受治疗的人类免疫缺陷病毒感染者的癌症归因死亡率

2017-07-0378
OAAI